Factory/PlantMaterials & chemicals

Tokuyama to expand aluminum nitride powder production capacity by 30% at Yanai center

Tokuyama CorporationYanai, YamaguchiPublished Sep 10, 2026

InvestmentNot disclosed

PhasePlanned

Start—

CompletionApr 2028

To completion

Today

20272028

About 18 months to scheduled completion.

Tokuyama will install new production equipment at its Advanced Technology Commercialization Center in Yanai, Yamaguchi, to increase aluminum nitride powder production capacity by approximately 30% from current levels. The facility is scheduled to begin commercial operation in April 2028, supporting demand from semiconductor manufacturing equipment components and thermal-management materials amid growing AI-related investment.

Project facts

Owner: Tokuyama Corporation
Listing: 4043 Tokyo
Facility: Factory/Plant
Sector: Materials & chemicals
Location: Yanai, Yamaguchi, Japan
Investment: Not disclosed
Scale / capacity: Approximately 30% increase from current production capacity
Completion: Apr 2028
Announced: Sep 10, 2026
Themes: AI-infrastructure, semiconductor-supply-chain

Figures and schedules are as announced by the company or the public body concerned; plans can change. Amounts that were not disclosed are recorded as not disclosed, never estimated.

More from Tokuyama Corporation2 projects · ¥3.5B disclosedCompany profile →

Tokuyama opens new semiconductor polysilicon plant in Ho Chi Minh CityHo Chi Minh City, VietnamCompleted¥3.5B

Also in Yamaguchi5 projects · ¥100B disclosedOn the map →

Mitsubishi Shipbuilding to expand shipbuilding capacity at Choshu DejimaMitsubishi Heavy IndustriesPlanned¥100B Nishi-Ef to build new factory in ShimonosekiNishi-F Co., Ltd.Plannedn/d ZEON to build new single-wall carbon nanotube plant at TokuyamaZeon CorporationUnder constructionn/d Nippon Marine Foods to build new seafood-processing plant in ShimonosekiNippon Marine Foods Co., Ltd.Plannedn/d

Latest in Materials & chemicalsAll Materials & chemicals →

Osaka Soda to expand pharmaceutical-purification silica gel production equipment at Amagasaki plant

NewMaterials & chemicalsHyogoPlanned2026.10.21

Osaka Soda held a groundbreaking ceremony for an expansion of pharmaceutical-purification silica gel production equipment at its Amagasaki plant in Hyogo. The project is part of a combined investment of more than ¥10 billion at the Amagasaki and Matsuyama plants, intended to roughly double their combined production capacity to meet growing demand for pharmaceutical purification materials.

Zeon starts construction of multi-product research and pilot facility in Kawasaki

NewMaterials & chemicalsKanagawaUnder construction2026.10.20

Zeon has begun construction of a multi-product research and pilot facility at its Kawasaki Innovation Frontier Port in Kawasaki, Kanagawa. The facility will incorporate polymer processing steps including polymerization, hydrogenation, coagulation and drying, and is scheduled to begin operations in January 2028 to accelerate scale-up from laboratory development to mass production.

Fujifilm to expand CMP slurry production capacity at Arizona site

Materials & chemicalsArizonaPlanned$18M2026.10.14

FUJIFILM Corporation will invest approximately $18 million in its Mesa, Arizona production and development site to expand copper-wiring CMP slurry capacity and install new equipment for multi-product CMP slurry production. The new facilities are scheduled to begin operations in 2027, supporting growing demand from advanced semiconductor and packaging processes, including AI-related applications.

Osaka Soda to expand pharmaceutical silica gel production facilities at Matsuyama plant

Materials & chemicalsEhimePlanned¥10B2026.10.10

Osaka Soda held a groundbreaking ceremony for an expansion of pharmaceutical purification silica gel production facilities at its Matsuyama plant in Matsuyama, Ehime. The project is part of a plan investing more than JPY 10 billion across the Matsuyama and Amagasaki plants to roughly double combined production capacity, driven by growing demand from diabetes and obesity drug manufacturers.